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Abstract
 
Although CD4
 
1
 
 T cells have been shown to mediate protective cellular immunity against respira-
tory virus infections, the underlying mechanisms are poorly understood. For example, although
phenotypically distinct populations of memory CD4
 
1
 
 T cells have been identified in different
secondary lymphoid tissues, it is not known which subpopulations mediate protective cellular im-
munity. In this report, we demonstrate that virus-specific CD4
 
1
 
 T cells persist in the lung tissues
and airways for several months after Sendai virus infection of C57BL/6 mice. A large proportion
of these cells possess a highly activated phenotype (CD44
 
hi
 
, CD62L
 
lo
 
, CD43
 
hi
 
, and CD25
 
hi
 
) and
 
express immediate effector function as indicated by the production of interferon 
 
g
 
 after a 5-h re-
stimulation in vitro. Furthermore, intratracheal adoptive transfer of lung memory cells into 
 
b
 
2
 
m-
deficient mice demonstrated that lung-resident virus-specific CD4
 
1
 
 T cells mediated a substantial
degree of protection against secondary virus infection. Taken together, these data demonstrate
that activated memory CD4
 
1
 
 T cells persisting at mucosal sites play a critical role in mediating
protective cellular immunity.
 
Key words: immunologic memory • immunity • mucosal • paramyxovirus • CD4
 
1
 
 T lymphocytes
 
Introduction
 
CD4
 
1
 
 T lymphocytes play a major role in the immune re-
sponses to respiratory virus infections, such as those medi-
ated by influenza and parainfluenza viruses, through the
regulation of antibody production (1). In addition, it has
also been established that CD4
 
1
 
 T lymphocytes, in associa-
tion with CD8
 
1
 
 T cells, are involved in the cellular im-
mune response to this class of infection, although the mech-
anisms are unclear (1–4). In general, primed memory CD4
 
1
 
T cells accumulate more rapidly in the lung than naive T
cells and mediate accelerated virus clearance in immune-
competent mice (5). This protection is mediated at least in
part by IFN-
 
g 
 
production and does not depend on anti-
body (references 4 and 6; unpublished observations). Al-
though it is clear that CD4
 
1
 
 T cells play a role in protec-
tion, the recall of memory CD4
 
1
 
 T lymphocytes has
generally been difficult to study, as the memory cells are
present in the spleen at very low frequencies relative to
CD8
 
1
 
 T cells. For example, CD4
 
1
 
 frequencies established
to influenza and Sendai virus (a murine parainfluenza-1 vi-
rus) are typically in the range of 0.1% of CD4
 
1
 
 T cells in
the spleen, whereas memory CD8
 
1
 
 T cells tend to be
maintained at around 1–10% of CD8
 
1
 
 T cells (7–9). These
memory CD4
 
1
 
 T cells persist at stable frequencies in the
spleen and lymph nodes many months after the initial infec-
tion (7). However, the relative contribution of memory
CD4
 
1
 
 T cells from different anatomical sites to protective
cellular immune responses is unknown.
 
We have recently shown that memory CD8
 
1
 
 T cells
persist in the lung tissue and airways for over 1 yr after re-
covery from a respiratory virus infection and that the
numbers of cells present in the lungs correlates with the
degree of protective immunity (10, 11). Lung memory
CD8
 
1
 
 T cells express a highly activated phenotype and
can be induced to proliferate and express various effector
functions. Thus, we speculated that memory CD4
 
1
 
 T cell
would also persist in the lung after resolution of the initial
infection and that these cells would correlate with protec-
tive immunity. In this report, we show that functional
memory CD4
 
1
 
 T cells persist at very high frequencies in
the lungs after resolution of a Sendai virus infection. In ad-
dition, by intratracheal transfer of cells we show that these
lung memory CD4
 
1
 
 T cells provide a substantial degree of
protection against a secondary infection.
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Materials and Methods
 
Viruses, Animals, and Infections.
 
The Enders strain of Sendai
virus and influenza virus A/HK-x31 (x31, H3N2) were grown,
stored, and titrated as described previously (12, 13). Female
C57BL/6, B6.SJL-Ptprca Pep3b/BoyJ (Ly5.1
 
1
 
), and C57BL/6J-
B2mtm1Unc (
 
b
 
2m-deficient) mice were purchased from the An-
imal Breeding Facility at the Trudeau Institute, The Jackson Lab-
oratory, or Taconic Farms. Mice (6–12 wk) were anesthetized by
intraperitoneal injection with 2,2,2 tribromoethanol and infected
intranasally with 500 50% egg infectious doses (EID
 
50
 
) of Sendai
virus or 300 EID
 
50 
 
of x31 influenza virus.
 
Peptides.
 
Sendai virus peptides (hemagglutinin-neuraminidase
[HN]
 
421–436
 
 and nucleoprotein [NP]
 
324–332
 
), and influenza virus
(hemagglutinin [HA]
 
192–207
 
 and NP
 
366–374
 
) peptides were pur-
chased from New England Peptide Inc. Peptide purity was evalu-
ated using reverse-phase HPLC analysis.
 
Tissue Preparation.
 
Single cell suspensions were prepared from
spleens and mediastinal lymph nodes (MLNs) by passage through
cell strainers. Spleen cells were depleted of erythrocytes by treat-
ment with buffered ammonium chloride solution. Bronchoalveo-
lar lavage (BAL) cells were collected by lavage of the lungs 3–4
times with 1 ml of HBSS. Cells were prepared from lung tissue
by passing lavaged lungs through cell strainers. The cells were
subsequently resuspended in 80% isotonic percoll and layered
with 40% isotonic percoll. After centrifugation at 400 
 
g
 
 for 25
min, the cells at the 80%/40% interface were collected, washed,
and counted.
 
Enzyme-linked Immunospot Assay.
 
The relative frequencies
and numbers of IFN-
 
g
 
–secreting cells derived from spleen, lung,
MLN, and BAL tissues were determined after stimulation with
Sen-HN
 
421–436
 
, Flu-HA
 
192–207
 
, Sen-NP
 
324–332
 
, or Flu-NP
 
366–374
 
peptides in a standard enzyme-linked immunospot (ELISPOT)
assay system. In brief, 96-well Multiscreen HA nitrocellulose
plates (Millipore) were coated overnight at 4
 
8
 
C with 100 
 
m
 
l per
well of rat anti–mouse IFN-
 
g
 
 (clone R4-6A2; BD PharMingen),
at a concentration of 10 
 
m
 
g/ml. The plates were then washed and
blocked before the addition of titered numbers of responding
cells, irradiated (3,000 rad) syngeneic normal spleen cells, peptide,
and 10 U/ml rhIL-2. Plates were then incubated 24–48 h at 37
 
8
 
C
and developed overnight with a biotinylated detection antibody,
rat anti–mouse IFN-
 
g
 
 (clone XMG1.2; BD PharMingen), fol-
lowed by streptavidin–horseradish peroxidase (Sav-HRP; BD
PharMingen) for 2 h at room temperature. Visible spots of IFN-
 
g
 
–secreting cells were then enumerated using an Olympus SZH
stereo zoom microscope system. Absolute numbers of antigen-
specific CD4
 
1
 
 T cells were calculated based on the number of
live cells recovered per mouse tissue. The frequencies of antigen-
specific T cells were determined by correcting the data for the
number of CD4
 
1
 
 T cells put into the assay based on flow cyto-
metric data. The number of spots in wells containing irrelevant
peptides was below detection (
 
,
 
1 in 10
 
6
 
).
 
Intracellular IFN-
 
g
 
 Staining.
 
Cells isolated from the spleen,
MLNs, lung tissue, and BAL (after plastic adherence) were mixed
with naive spleen cells from Ly5.1
 
1
 
 H-2
 
b
 
 mice. The cells were
then cultured at 37
 
8
 
C for 5 h in the presence of 10 
 
m
 
g of the in-
dicated peptide in 250 
 
m
 
l complete tumor medium (CTM) con-
taining 10 
 
m
 
g/ml brefeldin A (BFA). After culture, the cells were
blocked with monoclonal antibodies to FcRIII/II receptor and
stained with anti-CD4–FITC, anti-Ly5.2 biotin, and streptavidin
Cychrome (BD PharMingen) in PBS/BFA. The cells were then
fixed in 1% formaldehyde, permeabilized with PBS containing
0.5% saponin, and stained with anti–IFN-
 
g
 
 PE or isotype control
IgG
 
1
 
 PE monoclonal antibodies. The data were acquired using a
FACScan™ flow cytometer and analyzed with CELLQuest™
software (Becton Dickinson).
Figure 1. CD41 T cells in the lung air-
ways (BAL) and lung tissues express an acti-
vated phenotype. Cells were isolated from
the spleen, MLNs, lung tissue, and lung air-
ways (BAL) of mice that had recovered
from a Sendai virus infection (day 41 after
infection). After isolation, the cells were
stained with anti-CD4–PE and FITC-con-
jugated CD44, CD62L, CD43, CD69, and
Ly6C antibodies. Cell surface expression of
CD25 was determined using anti-CD25–
PE and anti-CD4–FITC antibodies. The
histograms show the expression of the indi-
cated markers among live CD41 lympho-
cytes. The bars and numbers in each panel
show the percentage of CD41 cells expres-
sing the indicated marker. Data are repre-
sentative of four independent experiments. 
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Intratracheal Cell Transfer.
 
BAL cells were collected from
C57BL/6 mice at 
 
.
 
35 d after Sendai virus or influenza virus in-
fection. The donor cells washed and resuspended in PBS at a
concentration of 10
 
7
 
 cells/ml. Naive C57BL/6 or 
 
b
 
2m-deficient
recipient mice were anesthetized and 100 
 
m
 
l (0.5–1 
 
3
 
 10
 
6
 
 cells)
of the cell suspension or PBS were instilled into the lungs (via the
trachea) using a 1-ml syringe fitted with a blunted 20-G needle.
Cells isolated from the BAL of mice that have recovered from a
Sendai virus infection typically contain 
 
,
 
0.5% B cells or plasma
cells, as determined by flow cytometric analysis using antibodies
specific for B220, CD19, and CD138.
 
Results and Discussion
 
Activated CD4
 
1
 
 T Cells Persist in the Lungs After Resolution
of a Primary Sendai Virus Infection.
 
To determine whether
CD4
 
1
 
 T cells persisted in the lungs after recovery from a
Sendai virus infection, we isolated cells from both the lung
tissue and airways at day 41 after Sendai virus infection.
Substantial numbers of CD4
 
1
 
 T cells were detected in both
the lung tissue and airways, ranging from 30,000 to
100,000 cells per mouse lung (data not shown). Phenotypic
analysis indicated that the CD4
 
1
 
 T cell populations in the
spleen, MLNs, lung airways, and lung tissue displayed re-
markably different phenotypes. As shown in Fig. 1, the vast
majority of CD4
 
1
 
 T cells isolated from the BAL displayed
high levels of CD44, low levels of CD62L, and low levels
of Ly6C expression, indicating that they are predominantly
“memory” T cells. In contrast, the levels of CD44 and
CD62L expression in the lung tissue indicate that both na-
ive and “memory” CD4
 
1
 
 T cells are present at this site.
As expected, the CD44/CD62L profile from the spleen
and MLNs show a large number of naive T cells
(CD44
 
lo
 
CD62L
 
hi
 
) and a much smaller number of antigen-
experienced CD4
 
1
 
 T cells (CD44
 
hi
 
CD62L
 
lo
 
).
Analysis of the CD4
 
1
 
 T cells in the BAL showed that a
large proportion of the cells were of a highly activated phe-
notype, characterized by the expression of acute activation
markers, CD43 and CD69. In contrast, much lower fre-
quencies of CD4
 
1
 
 T cells isolated from the lung tissue,
MLNs, and spleen expressed CD43 and CD69. This differ-
ence in phenotype persisted even when CD4
 
1
 
CD44
 
hi
 
“memory” T cells were analyzed separately. Thus, as
shown in Table I, a large proportion of cells isolated from
the BAL fluid possess an activate phenotype as indicated by
CD43 and CD69 expression. In contrast, decreasing lev-
els of activation marker expression were observed on
CD4
 
1
 
CD44
 
hi
 
 “memory” T cells in the lung tissue, spleen,
and MLNs. This pattern of activation marker expression is
remarkable given that many weeks have passed since reso-
lution of the primary infection and is very similar to the de-
scription of CD8
 
1
 
 memory T cells that persist in the lungs
after recovery from Sendai or influenza virus infections
(11). Although the activated phenotype of the cells in the
lungs suggests that a pool of viral antigen may persist, we
and others have been unable to demonstrate persistent viral
antigen by PCR or by using a sensitive virus-specific hy-
bridoma assay (data not shown; reference 14).
 
Virus-specific Effector CD4
 
1
 
 T Cells Persist in the Lungs Af-
ter Sendai Virus Infection.
 
To determine whether any of
the CD4
 
1
 
 T cells that persisted in the lung were virus spe-
cific, we performed ELISPOT assays using cells isolated
from the BAL, lung tissue, spleen, and MLNs of Sendai
memory mice (day 41 after infection). The antigen used
for these studies was a peptide representing an immu-
nodominant I-A
 
b
 
–restricted epitope derived from the HN
protein. Previous studies had shown that this epitope
drives about 15% of the CD4
 
1
 
 T cell response to Sendai
virus infection in the lung (reference 15; and data not
shown). As shown in Table II, a substantial population of
HN
 
421–436
 
/A
 
b
 
-specific CD4
 
1
 
 T cells, representing 
 
.
 
13%
of the total CD4
 
1
 
 T cell pool), is present in the BAL after
resolution of the primary infection. Interestingly, the fre-
quency of HN
 
421–436
 
/A
 
b
 
-specific CD4
 
1
 
 T cells in the lungs
is much higher than the frequencies of HN
 
421–436
 
/A
 
b
 
-spe-
cific cells in the spleen and MLNs. For example the fre-
quency of antigen-specific CD41 T cells in the BAL is
.200-fold higher than in the spleen (Table II). When ab-
solute numbers of cells were compared, the population of
virus-specific CD41 T cells in the lungs (BAL and tissue)
was more than twice the number isolated from the MLNs
and z20% of the number in the spleen. Phenotypic and
ELISPOT analyses of cells isolated from the lungs of mice
90 d after Sendai virus infection showed similar results, in-
dicating that antigen-specific CD41 T cells persist in the
lungs for .11 wk after infection.
As a control for these studies, we also determined the
frequencies of CD81 T cells in the lungs specific for the
immunodominant NP324–332/Kb epitope by ELISPOT
analysis (16). As expected, NP324–332/Kb-specific CD81 T
cells are present at very high frequencies and absolute num-
Table I. The Proportion of CD41CD441 Cells Expressing the 
Indicated Markers After Sendai Virus Infection
CD41CD441
Percent
CD441
among
CD41 CD62L1 CD431 CD691 CD251 Ly6C1
BAL
(n 5 5)* 8 2 6 7 24 02 31 3
Lung tissue
(n 5 3) 36 15 63 17 9 20
MLNs
(n 5 3) 25 19 27 33 28 13
Spleen
(n 5 3) 26 28 38 25 15 25
Mice were intranasally infected with 500 EID50 Sendai virus and tissues
were analyzed on day 34 after infection.
*Data were generated by pooling cells isolated from the indicated num-
ber of mice.984 Persistence of CD41 T Cells in the Lungs
bers in the lung airways and lung tissue at day 41 after Sen-
dai virus infection (Table II), consistent with previous re-
ports (11). As an additional control, we also included an
influenza peptide representing a dominant I-Ab epitope
(HA421–436/Ab). This peptide was always negative (i.e., fre-
quencies of ,1:1 3 106) in these ELISPOT assays (data not
shown). Taken together, these data show that high fre-
quencies of antigen-specific memory CD41 T cells persist
in the lungs after recovery from a Sendai virus infection
and that these cells can be induced to secrete IFN-g in a
48-h restimulation (ELISPOT) assay.
Having established that activated virus-specific CD81
and CD41 T cells persist in the lungs, we next investigated
the ability of both populations to produce IFN-g directly
ex vivo using an intracellular cytokine assay. Cells were iso-
lated from the lung airways of Sendai memory mice (40 d
after infection) by lavage and restimulated for 5 h in vitro
in the presence of BFA, peptide, IL-2, and Ly5.11 spleen
cells. Ly5.11 spleen cells were used as APCs to allow us to
specifically examine IFN-g production in the BAL cell
population (Ly5.21). As shown in Fig. 2, stimulation with
PMA and ionomycin induced IFN-g production in z15%
of both CD41 and CD81 T cells. Furthermore, significant
populations of CD41 and CD81 BAL cells also produced
IFN-g after stimulation with the relevant Sendai virus pep-
tides. In contrast, memory cells cultured with irrelevant
control peptides corresponding to the CD4 and CD8 im-
munodominant epitopes of influenza virus produced only
background levels of IFN-g (Fig. 2). Staining with an iso-
type control antibody also confirmed the specificity of
the assay. In additional experiments, BAL cells were la-
beled with carboxyfluorescein diacetate-succinimidyl ester
Table II. ELISPOT Analysis of Virus-specific T Cells in the BAL, Lung Tissue, MLNs, and Spleens of C57BL/6 Mice After Resolution of 
a Primary Sendai Virus Infection
Sendai HN421–436 Sendai NP324–332
Sen-HN421–436
specific among
CD41
Total no. of
Sen-HN421–436–specific
cells per mouse
Sen-NP324–332
specific among
CD81
Total no. of 
Sen-NP324–332–specific
cells per mouse
%%
BAL (n 5 9)* 13.2 1,964 59.5 11,032
Lung tissue (n 5 8) 2.1 1,679 13.9 7,400
MLNs (n 5 8) 0.11 1,512 0.37 4,992
Spleen (n 5 3) 0.06 18,320 0.44 88,578
Mice were intranasally infected with 500 EID50 Sendai virus and tissues were analyzed on day 41 after infection. Data are representative of two
independent experiments.
*Data were generated by pooling cells isolated from the indicated number of mice.
Figure 2. BAL memory cells produce
IFN-g directly ex vivo. Cells were isolated
from the lung airways (BAL) of mice that had
recovered from Sendai virus infection (day
34). The cells were restimulated with PMA/
ionomycin or Sen-HN421–436, Flu-HA192–207,
Sen-NP324–332, or Flu-NP366–374 peptides in
the presence of BFA, IL-2, and naive Ly5.11
spleen cells as APCs. After 5 h in culture, all
cells were stained with anti-Ly5.2 biotin fol-
lowed by streptavidin-allophycocyanin and
the indicated antibodies. The data are pre-
sented as live Ly5.21 lymphocytes (BAL).
The numbers indicate the percentages of
IFN-g–secreting cells among the total
Ly5.21CD81 or Ly5.21CD41 cell popula-
tion. Data are representative of three inde-
pendent experiments.985 Hogan et al. Brief Definitive Report
(CFSE) and restimulated in vitro. After a 4-d incubation,
BAL-derived CD41 T cells exhibited marked proliferation
(unpublished observations). Taken together, these data
confirm that functional virus-specific T cells persist in the
lungs and demonstrate that these cells can rapidly produce
high levels of IFN-g in response to relevant antigen (17).
CD41 Cells in the Lung Airways Can Mediate Protective Im-
munity. Given the ability of antigen-specific T cells in the
lungs to rapidly produce IFN-g directly ex vivo, we next
asked whether these cells would mediate protection against
subsequent Sendai virus infection. Thus, total BAL cells
were isolated from the lungs of mice that had recovered
from a Sendai virus infection (day 35 after infection) and
intratracheally transferred directly into the lungs of naive
C57BL/6 mice. This procedure instills cells directly into
the lung airways and it has been shown that these cells are
able persist in the airways for several weeks after transfer
(unpublished observations). 4 h after transfer, the mice
were infected with Sendai virus and viral titers in the lung
were then assessed 4 d later. As shown in Fig. 3 A, mice
that received the memory BAL cells had a significantly re-
duced viral load in the lung compared with PBS control
mice (an average reduction of 250-fold, P 5 0.014). Al-
though the intratracheal transfer of memory BAL cells had
a significant impact on lung virus titers, it was not clear ex-
actly which cells in the BAL mediated this effect, or
whether CD41 T cells were involved. Thus, to specifically
investigate the role of virus-specific CD41 T cells in the
lung airways, we intratracheally transferred Sendai memory
BAL cells (day 40 after infection) into naive b2m-deficient
mice. These mice express undetectable levels of H-2Kb re-
sulting in a significant impairment of the CD81 T cell re-
sponse to the immunodominant NP324–332/Kb-epitope (16,
18). It should be noted that b2m-deficient mice do express
low levels of functional H-2Db, but that this restricting ele-
ment is not involved in the effector CD81 T cell response
to Sendai virus in H-2b mice (16). Two sets of control
b2m-deficient mice received either PBS or BAL cells iso-
lated from influenza memory mice (day 41 after infection).
As shown in Fig. 3 B, the b2m-deficient mice that received
Sendai memory BAL cells were significantly more efficient
at controlling the virus load than the PBS control group
(P , 0.009) or the influenza control group (P , 0.023).
These data cannot be readily explained by the transfer of
memory B or antibody-producing plasma cells, as these
cells typically represent ,0.5% of the cells in the BAL.
Similarly, the fact that the BAL cells were washed before
transfer rules out the transfer of passive antibody. Thus, the
data suggest that the presence of virus-specific CD41 T
cells in the lungs has a significant impact on viral load dur-
ing the initial stages of infection.
The mechanism by which CD41 T cells mediate protec-
tion against respiratory virus infections is unclear. How-
ever, there is substantial evidence that IFN-g production is
a key player in this protection. In this regard, the presence
of both CD41 and CD81 T cells in the lungs capable of
rapidly producing IFN-g is consistent with the idea that
this cytokine plays a critical role. The absolute numbers of
antigen-specific CD41 T cells in the lung is relatively small
(z20% of the number in the spleen; Table II). But these
cells are present in a highly activated state and are able to
respond immediately at the site of infection when the viral
load is still very low. Thus, a relatively small number of
cells may be sufficient to have a significant impact on the
early stages of the infection, especially if the cells proliferate
and mediate sustained cytokine production. In addition,
these cells may function to rapidly recruit other inflamma-
tory cells to the site of infection through the production of
chemokines. We have also shown that the development of
an effective CD41 T cell response depends on the presence
of CD81 T cells, suggesting a regulatory role for CD81 T
cells (unpublished observations). It should be noted that
both CD41 and CD81 T cells were physically present in
the intratracheal transfer experiments that demonstrated
protective immunity, but that the CD81 T cell function
was significantly impaired due to a deficient H-2Kb expres-
sion on the host respiratory epithelium.
It is currently unclear how memory cells persist in the
lung tissues and airways. Based on observations with the
CD81 memory T cells, we have speculated that memory
CD41 and CD81 cells in the spleen are slowly dividing and
that some of the activated cells enter the circulation (10,
11). Given the activated phenotype of these cells, they are
likely to accumulate in mucosal tissues, including the lung
and lung airways. For example, there is substantial evidence
that activated T cells accumulate in the lung and extrava-
sate across epithelium into the airways (19). The absolute
Figure 3. BAL memory cells
confer protection against Sendai
virus infection. (A) 10 naive
C57BL/6 mice were intranasally
infected with 500 EID50 Sendai
virus. 4 h before infection, the
mice received either memory
BAL cells (5 3 105 cells in 100
ml, n 5 5), or control PBS (100
ml, n 5 5) intratracheally. The
BAL cells in this experiment
were derived from C57BL/6
mice that had recovered from in-
fection with 500 EID50 Sendai
virus (35 d after infection). (B)
16 naive b2m-deficient mice
were intranasally infected with
500 EID50 Sendai virus. 4 h be-
fore infection, each mouse re-
ceived either Sendai memory
BAL cells (106 cells in 100 ml,
n 5 6), influenza memory BAL
cells (106 cells in 100 ml, n 5 6),
or control PBS (100 ml, n 5 4)
intratracheally. In this experi-
ment, Sendai memory BAL cells
were obtained from C57BL/6 mice at day 40 after infection, whereas in-
fluenza memory BAL cells were obtained from C57BL/6 mice at day 41
after infection. In both A and B, virus titers in the lung were determined
4 d after transfer by titrating lung homogenates in embryonated chicken
eggs, followed by hemagglutination assays. Where indicated, the differ-
ence in viral titers among each group was determined to be statistically
significant as based on a standard t test. The data are expressed as
log10EID50 and are representative of three independent experiments.986 Persistence of CD41 T Cells in the Lungs
number of cells in the lung would depend on the relative
numbers and replication rates of memory cells in secondary
lymphoid organs that seed the circulation, and the length of
time that the cells persist at mucosal sites. In support of this
general idea, we have shown that vaccination protocols
that do not involve infection of the lung nevertheless in-
duce substantial populations of memory CD41 and CD81
T cells in the lungs (data not shown).
Taken together, the data demonstrate that memory
CD41 T cells with an activated phenotype and capable of
immediate effector function persist at very high frequencies
in the lungs after resolution of a respiratory virus infection,
and that these cells are capable of mediating protective cel-
lular immunity. These findings have significant implica-
tions for our understanding of cellular immunity to infec-
tion and vaccine development.
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